Healio6d
Adults who receive Epstein–Barr donor kidneys face risk of post-transplant complications
Patients who receive kidney transplants from Epstein–Barr virus D-positive/R-negative donors face a higher risk of ...
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Atara Biotherapeutics, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Studies Show Long COVID Risk In Women, SARS-CoV-2 And Chronic Fatigue Link
Risk of long COVID is higher in women and a link between SARS-CoV-2 infection and development of ME/CFS is shown, according ...
AI advancement in T cell epitope prediction could propel vaccine development
A collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging ...
ascopubs.org7d
Transcriptomic features of Epstein-Barr virus-associated gastric cancer based on PD-L1 status.
Use of immune repertoire sequencing analysis to detect differences in treatment responses for advanced esophageal squamous cell carcinoma treated with camrelizumab and platinum-based chemotherapy.
News Medical on MSN5d
New AI tool promises faster vaccine development by predicting T cell epitopes
An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...
Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Too Old to Operate11d
Impact of Letermovir Prophylaxis on EBV Reactivation After Haploidentical HSCT
The following is a summary of “Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection ...
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...